# Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)

> **NCT00671528** · PHASE4 · TERMINATED · sponsor: **Organon and Co** · enrollment: 3 (actual)

## Conditions studied

- Dermatitis, Atopic
- Eczema, Atopic
- Skin Diseases, Eczematous

## Interventions

- **DRUG:** Cream (betamethasone diproprionate, clotrimazole, and gentamicin sulfate)
- **DRUG:** Cream (betamethasone diproprionate and gentamicin)
- **DRUG:** Cream (betamethasone diproprionate)

## Key facts

- **NCT ID:** NCT00671528
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** terminated early due to lack of recruitment \[only 3 of 207 subjects were enrolled\]
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00671528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00671528, "Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00671528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*